CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC - Insider Non-Derivative Transactions at STANDARD BIOTOOLS INC. (LAB) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 4, 2025, CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC's relationship to STANDARD BIOTOOLS INC. (LAB) is Director, and currently has 53,775,821 shares of Common Stock, and 72,100,000 shares of Common Stock, $0.001 par value per share.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LAB insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC - Insider Non-Derivative Transactions of LAB Common Stock

CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC - Insider Non-Derivative Transactions of LAB Common Stock, $0.001 par value per share

CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC - Insider Non-Derivative Transactions at LAB

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 5, 2025	P -- (Common Stock, $0.001 par value per share)	150000	1.45	72100000
Dec 4, 2025	P -- (Common Stock, $0.001 par value per share)	75000	1.44	71950000
Dec 3, 2025	P -- (Common Stock, $0.001 par value per share)	125000	1.42	71875000
Aug 27, 2024	P -- (Common Stock)	150000	2.15	53775821
Aug 24, 2024	P -- (Common Stock)	292100	2.13	53625821
Aug 23, 2024	P -- (Common Stock)	307900	1.96	53333721